GABAB receptor antagonist 5 (Compound 23) is a competitive antagonist of the GABAB receptor. It holds potential for research into neuropsychiatric disorders, including epilepsy, depression, and addiction.
Target:
GABA Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
